Search research articles
Contact Us
Filters
Showing results (131-140 of 206) with videos related to
Page
of 21
Sort By:
Cancer Science
|
July 2, 2021
Antitumor effect of WEE1 blockade as monotherapy or in combination with cisplatin in urothelial cancer
Kaoru Murakami, Yuki Kita, Toru Sakatani, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
June 14, 2021
[Complete Remission of Metastatic Renal Cell Carcinoma with Invasion of the Duodenum and Pancreas after Treatment with Nivolumab Plus Ipilimumab Followed by Axitinib and Surgery : A Case Report]
Hiroki Hagimoto, Toshinari Yamazaki, Soki Kashima, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
April 24, 2018
[Two Cases of Metastatic and Recurrent Non-Clear Cell Renal Cell Carcinoma Re-Diagnosed as Renal Mucinous Tubular and Spindle Cell Carcinoma during Long-Term Follow-Up]
Masashi Kubota, Toshinari Yamasaki, Yuki Teramoto, et al.
Nagoya Journal of Medical Science
|
April 21, 2025
A case of severe immune-related adverse events, myocarditis with myositis, and myasthenia gravis overlap syndrome following adjuvant nivolumab administration for muscle-invasive bladder cancer
Hiroki Kamikawa, Yoshihisa Matsukawa, Hisae Nishii, et al.
IJU Case Reports
|
September 11, 2020
Solitary recurrence of prostate cancer surrounded by seminal vesicle/vas deferens-like epithelium
Hajime Takamori, Tomomi Kamba, Shinji Sumiyoshi, et al.
Japanese Journal of Clinical Oncology
|
January 17, 2025
The real prevalence and clinical courses of non-metastatic castration-resistant prostate cancer: a retrospective single-institutional study
Hajime Takamori, Takayuki Goto, Soki Kashima, et al.
International Journal of Clinical Oncology
|
July 11, 2026
Combination of baseline and first-week neutrophil-to-lymphocyte ratio predicts overall survival in advanced renal cell carcinoma treated with first-line combination immunotherapy
Takeshi Sasaki, Shinichiro Higashi, Kouhei Nishikawa, et al.
Cancer Science
|
December 15, 2018
Initial evaluation of PET/CT with <sup>18</sup> F-FSU-880 targeting prostate-specific membrane antigen in prostate cancer patients
Tsuneo Saga, Yuji Nakamoto, Takayoshi Ishimori, et al.
Japanese Journal of Clinical Oncology
|
September 12, 2022
Prevalence and risk estimation of cancer-predisposing genes for upper urinary tract urothelial carcinoma in Japanese
Yuya Sekine, Yusuke Iwasaki, Nozomi Hakozaki, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
November 8, 2019
[Clinical Effect of Nivolumab on Advanced Renal Cell Carcinoma with Peritoneal Metastasis]
Takuya Hida, Toshinari Yamasaki, Haruka Banno, et al.
Page
of 21
Search research articles
Search
Showing results (131-140 of 206) with videos related to
Sort By:
Page
of 21
Cancer Science
|
July 2, 2021
Antitumor effect of WEE1 blockade as monotherapy or in combination with cisplatin in urothelial cancer
Kaoru Murakami, Yuki Kita, Toru Sakatani, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
June 14, 2021
[Complete Remission of Metastatic Renal Cell Carcinoma with Invasion of the Duodenum and Pancreas after Treatment with Nivolumab Plus Ipilimumab Followed by Axitinib and Surgery : A Case Report]
Hiroki Hagimoto, Toshinari Yamazaki, Soki Kashima, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
April 24, 2018
[Two Cases of Metastatic and Recurrent Non-Clear Cell Renal Cell Carcinoma Re-Diagnosed as Renal Mucinous Tubular and Spindle Cell Carcinoma during Long-Term Follow-Up]
Masashi Kubota, Toshinari Yamasaki, Yuki Teramoto, et al.
Nagoya Journal of Medical Science
|
April 21, 2025
A case of severe immune-related adverse events, myocarditis with myositis, and myasthenia gravis overlap syndrome following adjuvant nivolumab administration for muscle-invasive bladder cancer
Hiroki Kamikawa, Yoshihisa Matsukawa, Hisae Nishii, et al.
IJU Case Reports
|
September 11, 2020
Solitary recurrence of prostate cancer surrounded by seminal vesicle/vas deferens-like epithelium
Hajime Takamori, Tomomi Kamba, Shinji Sumiyoshi, et al.
Japanese Journal of Clinical Oncology
|
January 17, 2025
The real prevalence and clinical courses of non-metastatic castration-resistant prostate cancer: a retrospective single-institutional study
Hajime Takamori, Takayuki Goto, Soki Kashima, et al.
International Journal of Clinical Oncology
|
July 11, 2026
Combination of baseline and first-week neutrophil-to-lymphocyte ratio predicts overall survival in advanced renal cell carcinoma treated with first-line combination immunotherapy
Takeshi Sasaki, Shinichiro Higashi, Kouhei Nishikawa, et al.
Cancer Science
|
December 15, 2018
Initial evaluation of PET/CT with <sup>18</sup> F-FSU-880 targeting prostate-specific membrane antigen in prostate cancer patients
Tsuneo Saga, Yuji Nakamoto, Takayoshi Ishimori, et al.
Japanese Journal of Clinical Oncology
|
September 12, 2022
Prevalence and risk estimation of cancer-predisposing genes for upper urinary tract urothelial carcinoma in Japanese
Yuya Sekine, Yusuke Iwasaki, Nozomi Hakozaki, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
November 8, 2019
[Clinical Effect of Nivolumab on Advanced Renal Cell Carcinoma with Peritoneal Metastasis]
Takuya Hida, Toshinari Yamasaki, Haruka Banno, et al.
Page
of 21